Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation

Review article: drug-induced liver injury in clinical practice

(2015) E. Björnsson   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

(2010) K. D. S. Watt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Important Elements for the Diagnosis of Drug-Induced Liver Injury

(2010) Vijay K. Agarwal et al.   Clinical Gastroenterology and Hepatology

Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop

(2010) Robert J. Fontana et al.   HEPATOLOGY

Metabolic syndrome in liver transplant recipients: Prevalence, risk factors, and association with cardiovascular events

(2010) Ido Laish et al.   LIVER TRANSPLANTATION

Drug-Induced Liver Injury Network (DILIN) Prospective Study

(2009) Robert J. Fontana et al.   DRUG SAFETY

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY

Hepatotoxicity Caused by Both Tacrolimus and Cyclosporine after Living Donor Liver Transplantation

(2008) Nobuhiko Taniai et al.   JOURNAL OF NIPPON MEDICAL SCHOOL